The MedBiquitous Consortium is launching a new project called MEMS 2.0 that it hopes will offer a streamlined, efficient, and effective system for collecting data about continuing healthcare education provided in accordance with the FDA’s extended-release and long-acting opioid analgesics Risk Evaluation and Mitigation Strategy, known as ER/LA REMS. At the core of ER/LA REMS is a requirement to educate ER/LA opioid analgesics prescribers on how to safely and effectively prescribe ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.